Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|October 17, 2019
Aquaporins Involvement in Pancreas Physiology and in Pancreatic DiseasesTatjana Arsenijevic, Jason Perret, Jean-Luc Van Laethem, et al.Plos One|May 26, 2012
Murine 3T3-L1 adipocyte cell differentiation model: validated reference genes for qPCR gene expression analysisTatjana Arsenijevic, Françoise Grégoire, Valérie Delforge, et al.The Biochemical Journal|December 3, 2003
A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95Tatjana Arsenijevic, Chantal Degraef, Jacques E Dumont, et al.Oncology Letters|April 18, 2025
Non‑endemic non‑keratinizing nasopharyngeal carcinoma: Long‑term toxicity following chemoradiationJulija Jovanovic Ristivojevic, Natasa Jovanovic Korda, Vukac Vujanac, et al.Cell Cycle (Georgetown, Tex.)|May 25, 2006
G1/S Cyclins interact with regulatory subunit of PKA via A-kinase anchoring protein, AKAP95Tatjana Arsenijevic, Chantal Degraef, Jacques E Dumont, et al.Plos One|September 17, 2013
Pituitary adenylate cyclase activating peptide (PACAP) participates in adipogenesis by activating ERK signaling pathwayTatjana Arsenijevic, Françoise Gregoire, Jeanne Chiadak, et al.Cell Cycle (Georgetown, Tex.)|November 19, 2005
Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cellsSabine Paternot, Tatjana Arsenijevic, Katia Coulonval, et al.International Journal of Molecular Sciences|October 21, 2016
Involvement of JNK/NFκB Signaling Pathways in the Lipopolysaccharide-Induced Modulation of Aquaglyceroporin Expression in 3T3-L1 Cells Differentiated into AdipocytesJeanne Durendale Chiadak, Tatjana Arsenijevic, Francoise Gregoire, et al.Journal of Infection in Developing Countries|October 20, 2021
Clinical analysis of COVID-19 positive cancer inpatients in National Cancer Center in SerbiaAleksandar Stepanović, Tatjana Arsenijevic, Vesna Stankovic, et al.Cancers|February 11, 2023
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and ChallengesTatjana Arsenijevic, Katia Coulonval, Eric Raspé, et al.Pageof 3